CXCR3 and B-cell chronic lymphocytic leukemia: Interestingly, although CXCR3 expression correlates with a worse clinical outcome in melanoma, colon cancer, chronic B-cell lymphocytic leukemia, and renal cell carcinoma, reduced expression of CXCR3 in breast cancer has been associated with shorter survival.